BlackRock Fund Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $118M | Buy |
1,679,460
+208,289
| +14% | +$14.6M | 0.02% | 1075 |
|
|
2016
Q3 | $104M | Buy |
1,471,171
+80,186
| +6% | +$5.69M | 0.02% | 1024 |
|
|
2016
Q2 | $68M | Sell |
1,390,985
-51,866
| -4% | -$2.54M | 0.02% | 1292 |
|
|
2016
Q1 | $91.3M | Buy |
1,442,851
+23,389
| +2% | +$1.48M | 0.02% | 1030 |
|
|
2015
Q4 | $159M | Sell |
1,419,462
-63,919
| -4% | -$7.17M | 0.04% | 616 |
|
|
2015
Q3 | $143M | Buy |
1,483,381
+166,917
| +13% | +$16.1M | 0.04% | 649 |
|
|
2015
Q2 | $135M | Buy |
1,316,464
+681,409
| +107% | +$69.8M | 0.03% | 759 |
|
|
2015
Q1 | $39.4M | Buy |
635,055
+83,110
| +15% | +$5.16M | 0.01% | 1672 |
|
|
2014
Q4 | $24.2M | Buy |
551,945
+400,839
| +265% | +$17.6M | 0.01% | 1945 |
|
|
2014
Q3 | $8.55M | Buy |
151,106
+3,537
| +2% | +$200K | ﹤0.01% | 2447 |
|
|
2014
Q2 | $6.62M | Sell |
147,569
-17,073
| -10% | -$766K | ﹤0.01% | 2668 |
|
|
2014
Q1 | $8.05M | Buy |
+164,642
| New | +$8.05M | ﹤0.01% | 2524 |
|